ABBV

AbbVie Inc.

US StockNYSEPharmaceutical Preparations

Research the business. Follow the filings.

Financial information from SEC disclosures, with reporting periods kept in context.

Revenue

61.2B USDAnnual · FY 2025

Operating income

15.1B USDAnnual · FY 2025

Net income

4.2B USDAnnual · FY 2025

Total assets

134B USDAnnual · FY 2025

Equity

-3.3B USDAnnual · FY 2025

Operating cash flow

19B USDAnnual · FY 2025

ABBV · Chart

Chart provided by TradingView. Loading the chart connects your browser to TradingView and sends necessary technical information such as your IP address, page URL, and displayed symbol.

TradingView privacy policy

Reported financial information

History varies by metric. Only verified periods are shown; missing periods are not filled in.

Revenue

SEC EDGAR / XBRL · Annual

Selected period · FY 2025

61.2B USD

15 verified periods

2011-12-31 – FY 2025

USD

0B20B40B60B80B

12-312011

12-312012

FY2013

FY2014

FY2015

FY2016

FY2017

FY2018

FY2019

FY2020

FY2021

FY2022

FY2023

FY2024

FY2025

Scroll horizontally to explore the full history. Select a bar to inspect its value.

Operating income

Source: SEC EDGAR/XBRL

Loading SEC data…

Net income

Source: SEC EDGAR/XBRL

Loading SEC data…